Last piece from the announcement;
'The early review of this data is consistent with observations from previous studies. Once the data
is formally analysed it will be submitted to the FDA in the final dossier seeking approval to
commence the first in human TAVR study'
How long before we get the go-ahead to start Human Trials....what we've been waiting for.
Great times ahead.
Cheers Dabrru
- Forums
- ASX - By Stock
- AVR
- Ann: Key Animal Study for EFS Submission Completed
Ann: Key Animal Study for EFS Submission Completed, page-2
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$19.00 |
Change
0.110(0.58%) |
Mkt cap ! $365.2M |
Open | High | Low | Value | Volume |
$19.01 | $19.11 | $18.59 | $97.55K | 5.216K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 43 | $19.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.50 | 21 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 43 | 19.000 |
1 | 200 | 18.800 |
1 | 1000 | 18.600 |
3 | 1475 | 18.580 |
1 | 1000 | 18.550 |
Price($) | Vol. | No. |
---|---|---|
19.500 | 21 | 1 |
20.000 | 1800 | 4 |
20.100 | 100 | 1 |
20.120 | 420 | 1 |
20.400 | 678 | 1 |
Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online